Change in Principal Officer – MR LAI TEIK KIN

07 May 2019

Date of change 28 May 2019
Age 55
Gender Male
Nationality Singapore
Type of change Appointment
Designation Group Chief Executive Officer


Major/Field of Study
Additional Information
University of Queensland, Australia

Working experience and occupation Earlier in his career and before co-founding the Nova MSC Group, Mr Lai Teik Kin was in involved in implementation of large scale & regional e-government projects. Since 1999, Teik Kin has served as both Executive Director and Chief Executive Officer of novaHEALTH Pte Ltd, a wholly owned subsidiary of the Nova MSC Bhd, spearheading the Groups foray into healthcare industry.From 2005-2012, Teik Kin also served as an Independent Non-Executive Director on the Board of MTouche Berhad, a public-listed company in Malaysia which is a forerunner and leader in wireless network technologies, mobile messaging services and interactive media applications.

In 2016, Teik Kin was appointed Business Mentor to the Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator to provide business insights and guidance.

In 2018, Teik Kin spearheaded a spin-off of EyRIS jointly with Singapore Eye Research Institue (SERI) and National University of Singapore-School of Computing (NUS-SoC) to develop and commercialize the artificial intelligence (AI) solutions for the healthcare industry. SELENA+, our first AI solution, performs automated image analysis for eye diseases such diabetes retinopathy with add-on modules for glaucoma and age-related macular degeneration.

Directorships in public companies and listed issuers (if any) Nil
Family relationship with any director and/or major shareholder of the listed issuer Nil
Any conflict of interests that he/she has with the listed issuer Nil
Details of any interest in the securities of the listed issuer or its subsidiaries 4,630,170 ordinary shares in Nova MSC Bhd
19,999 ordinary shares in EyRIS Pte Ltd

Comments are closed.